الإحصائيات الأساسية
| CIK | 1481646 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Accolade, Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| April 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. 001-39348 Commission File Number ACCOLADE, INC. (Exact name of registrant as specified in its charte |
|
| April 8, 2025 |
As filed with the Securities and Exchange Commission on April 8, 2025 As filed with the Securities and Exchange Commission on April 8, 2025 Registration No. |
|
| April 8, 2025 |
Exhibit 2.2 March 28, 2025 Rob Cavanaugh Sent via email: [redacted]@accolade.com Dear Rob: This letter sets forth the terms of your separation from Accolade, Inc. (the “Agreement”). The term “Company Party(ies)” shall refer to Accolade, Inc. (the “Company”) and any of its parents, subsidiaries, or affiliates, and any of their successors-in-interest. 1. General Matters Relating to Your Separation. |
|
| April 8, 2025 |
As filed with the Securities and Exchange Commission on April 8, 2025 As filed with the Securities and Exchange Commission on April 8, 2025 Registration No. |
|
| April 8, 2025 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ACCOLADE, INC. ARTICLE I Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ACCOLADE, INC. ARTICLE I The name of the corporation is Accolade, Inc. (the “Company”). ARTICLE II The address of the Company’s registered office in the State of Delaware is 1209 Orange Street, in the City of Wilmington, County of New Castle, Delaware 19801. The name of the registered agent at such address is The Corporation Trust Co |
|
| April 8, 2025 |
As filed with the Securities and Exchange Commission on April 8, 2025 As filed with the Securities and Exchange Commission on April 8, 2025 Registration No. |
|
| April 8, 2025 |
As filed with the Securities and Exchange Commission on April 8, 2025 As filed with the Securities and Exchange Commission on April 8, 2025 Registration No. |
|
| April 8, 2025 |
AMENDED AND RESTATED BYLAWS OF ACCOLADE, INC. TABLE OF CONTENTS Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ACCOLADE, INC. TABLE OF CONTENTS Page ARTICLE I — MEETINGS OF STOCKHOLDERS 1 1.1 Place of Meetings 1 1.2 Annual Meeting 1 1.3 Special Meeting 1 1.4 Notice of Stockholders’ Meetings 2 1.5 Quorum 2 1.6 Adjourned Meeting; Notice 2 1.7 Conduct of Business 2 1.8 Voting 3 1.9 Stockholder Action by Written Consent Without a Meeting 3 1.10 Record Dates 4 1.11 Pro |
|
| April 8, 2025 |
Exhibit 4.1 EXECUTION VERSION ACCOLADE, INC. AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (as successor in interest to U.S. BANK NATIONAL ASSOCIATION), as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of April 8, 2025 0.50% Convertible Senior Notes due 2026 FIRST SUPPLEMENTAL INDENTURE, dated as of April 8, 2025 (this “Supplemental Indenture”), among Accolade, Inc., a Delaware corporation (th |
|
| April 8, 2025 |
Exhibit 2.3 March 28, 2025 Richard Eskew Sent via email: [redacted]@accolade.com Dear Rich: This letter sets forth the terms of your separation from Accolade, Inc. (the “Agreement”). The term “Company Party(ies)” shall refer to Accolade, Inc. (the “Company”) and any of its parents, subsidiaries, or affiliates, and any of their successors-in-interest. 1. General Matters Relating to Your Separation. |
|
| April 8, 2025 |
As filed with the Securities and Exchange Commission on April 8, 2025 As filed with the Securities and Exchange Commission on April 8, 2025 Registration No. |
|
| April 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 2025 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 27, 2025 |
Accolade Stockholders Approve Merger Between Accolade and Transcarent Exhibit 99.1 Accolade Stockholders Approve Merger Between Accolade and Transcarent Seattle, WA, March 27, 2025 – Accolade (NASDAQ:ACCD) announced that Accolade stockholders voted to approve the merger with Transcarent at the Accolade special meeting of stockholders (the “Special Meeting”) held earlier today. The final, certified voting results for the Special Meeting will be provided in a Form 8-K |
|
| March 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2025 ACCOLADE, INC. (Exact name of registrant as specified in its charter) Commission File Number 001-39348 Delaware 01-0969591 (State or other jurisdiction of incorporation |
|
| March 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| February 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| February 20, 2025 |
DEFM14A 1 ny20041213x9defm14a.htm DEFM14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act Of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission O |
|
| February 10, 2025 |
TABLE OF CONTENTS PRELIMINARY PROXY STATEMENT — SUBJECT TO COMPLETION, DATED FEBRUARY 10, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 10, 2025 |
Exhibit 107 Calculation of Filing Fee Table SCHEDULE 14A (Form Type) Accolade, Inc. |
|
| January 30, 2025 |
EX-99.1 2 tm254864d1ex-1.htm EXHIBIT I EXHIBIT I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.0001 per share, of Accolade, Inc. will be filed on behalf of each of the |
|
| January 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| January 21, 2025 |
Exhibit 99.3 SCHEDULE A Funds Date Number of Shares Bought Price Per Share($) (1)(2) 01/08/2025 2,306,633 6.862221 (3) 01/10/2025 1,079,526 6.842673 (4) 01/13/2025 487,864 6.853661 (5) 01/14/2025 378,734 6.850986 (6) 01/15/2025 420,579 6.855742 (7) 01/16/2025 221,690 6.863463 (8) 01/17/2025 240,645 6.876016 (9) (1) Excludes commissions and other execution-related costs. (2) Upon request by the sta |
|
| January 21, 2025 |
EXHIBIT 99.2 LIMITED POWER OF ATTORNEY Know all by these present, that I, David J. Snyderman, hereby make, constitute and appoint each of Michael Turro, Karl Wachter and Hayley Stein, or any of them acting individually, and with full power of substitution, as my true and lawful attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as Manager or |
|
| January 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| January 21, 2025 |
ACCD / Accolade, Inc. / Magnetar Financial LLC - EXHIBIT 99.1 JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13D with respect to the Shares of Accolade, Inc. dated as of January 21, 2025 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the previsions of Rule13d-1(k) under the Securi |
|
| January 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| January 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| January 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 |
|
| January 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| January 8, 2025 |
Exhibit 99.1 Transcarent To Acquire Accolade Combined company creates industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment Transcarent’s Generative AI WayFinding and care experiences combined with Accolade’s Advocacy, Expert Medical Opinion, and Primary Care will deliver on the promise of ‘One Place for Health and Care’ Accolade share |
|
| January 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2025 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| January 8, 2025 |
Exhibit 10.1 CONFIDENTIAL VOTING AGREEMENT VOTING AGREEMENT (this “Voting Agreement”), dated as of January [●], 2025, by and among Transcarent, Inc., a Delaware corporation (“Parent”), Acorn Merger Sub, Inc., a Delaware corporation and a wholly owned indirect subsidiary of Parent (“Merger Sub”), and the undersigned stockholder of Accolade, Inc., a Delaware corporation (the “Company” and such stock |
|
| January 8, 2025 |
Agreement and Plan of Merger, dated as of January 8, 2025, by and among Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among Accolade, Inc., Transcarent, Inc. and Acorn Merger Sub, Inc. Dated as of January 8, 2025 TABLE OF CONTENTS (continued) Page ARTICLE I THE MERGER 1 Section 1.1 Merger of Merger Sub into the Company 1 Section 1.2 Effect of the Merger 1 Section 1.3 Closing; Effective Time. 2 Section 1.4 Certificate of Incorporation and Bylaws; Di |
|
| January 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2025 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| November 14, 2024 |
ACCD / Accolade, Inc. / Bellevue Group AG - SC 13G/A Passive Investment SC 13G/A 1 d884186dsc13ga.htm SC 13G/A United States SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Accolade, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00437E102 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing This Statement) Check the appropriate box to designate the |
|
| October 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2024 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 A |
|
| October 8, 2024 |
Accolade Announces Results for Fiscal Second Quarter 2025 Exhibit 99.1 Accolade Announces Results for Fiscal Second Quarter 2025 SEATTLE, October 8, 2024 - Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2024. “As we enter the second half of fiscal year 2025, we are well positioned to deliver our first full year of Adjusted EBITDA profitability and positive cash flow. Accolade is proving the |
|
| October 7, 2024 |
ACCD / Accolade, Inc. / INTEGRATED CORE STRATEGIES (US) LLC Passive Investment SC 13G 1 ACCDSC13G.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 ACCOLADE, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 00437E102 (CUSIP Number) OCTOBER 3, 2024 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule |
|
| August 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2024 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| July 3, 2024 |
ACCD / Accolade, Inc. / JPMORGAN CHASE & CO - FILING ACCOLADE, INC. Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 02)* ACCOLADE, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 00437E102 (CUSIP Number) June 28, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| June 27, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2024 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| June 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 ACCO |
|
| June 27, 2024 |
Accolade Announces Results for Fiscal First Quarter 2025 Exhibit 99.1 Accolade Announces Results for Fiscal First Quarter 2025 SEATTLE, June 27, 2024 - Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024. “Accolade's physician-led advocacy approach to solving the Physician Gap is increasing accessibility to healthcare and improving outcomes for the millions of lives we service. We will continue |
|
| June 21, 2024 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 26, 2024 |
EX-FILINGFEES Calculation of Filing Fee Table Form S-8 (Form Type) Accolade, Inc. (Exact name of Registrant as Specified in its Charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $0.0001 par valu |
|
| April 26, 2024 |
Subsidiaries of the Registrant Exhibit 21.1 Accolade, Inc. Subsidiaries of the Registrant The following is a list of the Company’s consolidating subsidiaries as of February 29, 2024. Name of Subsidiary State or Jurisdiction of Incorporation Accolade Techologies s.r.o. Czech Republic MD Insider, Inc. Delaware Accolade 2ndMD LLC Texas 1stMD LLC Texas PlushCare, Inc. Delaware PlushCare Technologies Canada, Inc. Canada |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 29, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 ACCOLAD |
|
| April 26, 2024 |
Exhibit 97 ACCOLADE - DODD-FRANK CLAWBACK POLICY Accolade (“Company”) has adopted this clawback policy (the “Policy”) as a supplement to any other clawback policies in effect now or in the future at the Company. |
|
| April 26, 2024 |
Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Accolade, Inc. (Exact name of registrant as specified in its charter) Delaware 01-0969591 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 1201 Third Avenue, Suite 1700 Seattle, WA 98101 |
|
| April 25, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2024 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| April 25, 2024 |
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024 Exhibit 99.1 Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024 SEATTLE, April 25, 2024 - Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 29, 2024. "Accolade has built a rare healthcare services business at scale with consistently strong growth rates. Whether serving consumers, employers, health plans, |
|
| February 16, 2024 |
(in thousands, except percentages) February 16, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, NE Washington, DC 20549 Attention: Angela Lumley Suying Li Re: Accolade, Inc. Form 10-K for Fiscal Year Ended February 28, 2023 Form 10-Q for Fiscal Quarter Ended November 30, 2023 Item 2.02 Form 8-K Dated January 8, 2024 File No. 001-39348 Ladies and Gentlem |
|
| February 13, 2024 |
HMIN / Homeinns Hotel Group / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0173-accoladeinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Accolade Inc Title of Class of Securities: Common Stock CUSIP Number: 00437E102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule p |
|
| February 13, 2024 |
HMIN / Homeinns Hotel Group / Bellevue Group AG - SC 13G/A Passive Investment SC 13G/A United States SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Accolade, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00437E102 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing This Statement) Check the appropriate box to designate the rule pursuant to which this Sc |
|
| February 9, 2024 |
HMIN / Homeinns Hotel Group / BROWN ADVISORY INC - BROWN ADVISORY INC Passive Investment SC 13G/A 1 accda120924.htm BROWN ADVISORY INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Accolade, Inc. (Name of Issuer) (Title of Class of Securities) 00437E102 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| January 29, 2024 |
HMIN / Homeinns Hotel Group / ARK Investment Management LLC - SC 13G/A Passive Investment SC 13G/A 1 tm244117d6sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Accolade, Inc. (Name of Issuer) Common stock (Title of Class of Securities) 00437E102 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| January 16, 2024 |
HMIN / Homeinns Hotel Group / JPMORGAN CHASE & CO - FILING ACCOLADE, INC. Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* ACCOLADE, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 00437E102 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| January 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 |
|
| January 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2024 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| January 8, 2024 |
Accolade Announces Results for Fiscal Third Quarter 2024 Exhibit 99.1 Accolade Announces Results for Fiscal Third Quarter 2024 SEATTLE, January 8, 2024 - Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2023. “As we head into the new year, Accolade continues to define the future of how healthcare should be experienced in this country. Our unique combination of people and technology is creati |
|
| November 17, 2023 |
144 0001219071 XXXXXXXX LIVE 0001481646 Accolade, Inc. 001-39348 660 W. GERMANTOWN PIKE SUITE 500 PLYMOUTH MEETING PA 19462 610-834-2989 SINGH RAJEEV Officer Director Common Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917 358 2843.34 76232192 11/17/2023 NASDAQ Common 11/16/2023 Restricted Stock Vesting Issuer N 358 11/16/2023 Compensation N Rajeev Singh 1201 Third Avenue Suite |
|
| November 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2023 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| October 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 A |
|
| October 4, 2023 |
Accolade Announces Results for Fiscal Second Quarter 2024 Exhibit 99.1 Accolade Announces Results for Fiscal Second Quarter 2024 SEATTLE, October 4, 2023 - Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2023. “We are halfway through the 2024 fiscal year and the demand environment for our solutions remains strong. Accolade continues to lay the foundation to build a lasting, scalable business |
|
| October 4, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2023 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| August 9, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| June 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 ACCO |
|
| June 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 29, 2023 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| June 29, 2023 |
Accolade Announces Results for Fiscal First Quarter 2024 Exhibit 99.1 Accolade Announces Results for Fiscal First Quarter 2024 ● Accolade exceeds guidance for fiscal first quarter and raises guidance for fiscal year 2024 SEATTLE, June 29, 2023 - Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2023. “Our consistently strong financial results reinforce our belief that an advocacy-led care delivery |
|
| June 27, 2023 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 28, 2023 |
As filed with the Securities and Exchange Commission on April 28, 2023 As filed with the Securities and Exchange Commission on April 28, 2023 Registration No. |
|
| April 28, 2023 |
EX-FILINGFEES Calculation of Filing Fee Table Form S-8 (Form Type) Accolade, Inc. (Exact name of Registrant as Specified in its Charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $0.0001 par value |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 ACCOLADE, INC. (Exact nam |
|
| April 28, 2023 |
Subsidiaries of the Registrant Exhibit 21.1 Accolade, Inc. Subsidiaries of the Registrant The following is a list of the Company’s consolidating subsidiaries as of February 28, 2023. Name of Subsidiary State or Jurisdiction of Incorporation Accolade Techologies s.r.o. Czech Republic MD Insider, Inc. Delaware Accolade 2ndMD LLC Texas 1stMD LLC Texas PlushCare, Inc. Delaware PlushCare Technologies Canada, Inc. Canada |
|
| April 27, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2023 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| April 27, 2023 |
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2023 Exhibit 99.1 Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2023 ● Fiscal fourth quarter 2023 revenue of $99.0 million, a 6% increase compared to fiscal fourth quarter 2022 revenue of $93.8 million ● Fiscal year 2023 revenue of $363.1 million, a 17% increase compared to fiscal 2022 revenue of $310.0 million SEATTLE, April 27, 2023 - Accolade, Inc. (NASDAQ: ACCD) today announced |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| February 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2023 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| February 14, 2023 |
HMIN / Homeinns Hotel Group / Bellevue Group AG - SC 13G Passive Investment SC 13G United States SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 ACCOLADE, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 00437E102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Ru |
|
| February 14, 2023 |
EX-99.A 2 d615360dex99a.htm EX-99.A Exhibit A Joint Filing Statement We, the undersigned, hereby express our agreement that the attached Schedule 13G (including all amendments thereto) is filed on behalf of each of the undersigned. Bellevue Group AG Date: February 14, 2023 By: /s/ Michael Hutter Signatory Authority Name: Michael Hutter Title: Chief Financial Officer Date: February 14, 2023 By: /s/ |
|
| February 10, 2023 |
HMIN / Homeinns Hotel Group / ARK Investment Management LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. |
|
| February 9, 2023 |
HMIN / Homeinns Hotel Group / BROWN ADVISORY INC - BROWN ADVISORY INCORPORATED Passive Investment SC 13G 1 accd20923.htm BROWN ADVISORY INCORPORATED UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Accolade, Inc. (Name of Issuer) (Title of Class of Securities) 00437E102 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| February 9, 2023 |
HMIN / Homeinns Hotel Group / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Accolade Inc. Title of Class of Securities: Common Stock CUSIP Number: 00437E102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule |
|
| January 9, 2023 |
Accolade Announces Results for Fiscal Third Quarter 2023 EX-99.1 2 accd-20230109xex99d1.htm EX-99.1 Exhibit 99.1 Accolade Announces Results for Fiscal Third Quarter 2023 ● Fiscal third quarter 2023 revenue of $90.9 million, a 9% increase compared to fiscal third quarter 2022 revenue of $83.5 million SEATTLE, January 9, 2023 - Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2022. “Accolade e |
|
| January 9, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2023 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| January 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 |
|
| January 6, 2023 |
HMIN / Homeinns Hotel Group / JPMORGAN CHASE & CO - FILING ACCOLADE, INC. Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ACCOLADE, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 00437E102 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| October 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 6, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2022 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) ? ? ? ? Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| October 6, 2022 |
Accolade Announces Results for Fiscal Second Quarter 2023 Exhibit 99.1 ? Accolade Announces Results for Fiscal Second Quarter 2023 ? ? Fiscal second quarter 2023 revenue of $87.6 million, a 20% increase compared to fiscal second quarter 2022 revenue of $73.3 million SEATTLE, October 6, 2022 - Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2022. ?Accolade executed across all of our key initia |
|
| October 6, 2022 |
Exhibit 10.1 SEVENTH AMENDMENT TO CREDIT AGREEMENT This Seventh Amendment to Credit Agreement (this ?Amendment?) is made as of July 19, 2022, by and among Accolade, Inc. (?Borrower?), each of the Guarantors party hereto, the financial institutions signatory hereto (the ?Lenders?) and Comerica Bank, as agent for the Lenders (in such capacity, ?Agent?). RECITALS A.Borrower, Agent and Lenders entered |
|
| July 28, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2022 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| July 21, 2022 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2022 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| July 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 1, 2022 |
Form of Vesting Acceleration Agreement ACCOLADE, INC. EQUITY VESTING ACCELERATION AGREEMENT This Equity Vesting Acceleration Agreement (the ?Agreement?) is entered into by and between (the ?Executive?) and Accolade, Inc., a Delaware corporation (the ?Company?), and is effective as of (the ?Effective Date?). 1. Agreement. This Agreement shall terminate on the date the Executive?s employment with the Company terminates for a reason other |
|
| June 30, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2022 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) ? ? ? ? Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| June 30, 2022 |
Accolade Announces Results for Fiscal First Quarter 2023 Exhibit 99.1 ? Accolade Announces Results for Fiscal First Quarter 2023 ? ? Fiscal first quarter 2023 revenue of $85.5 million, a 44% increase compared to fiscal first quarter 2022 revenue of $59.5 million SEATTLE, June 30, 2022 - Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2022. ?The healthcare consumer has never been more in need of |
|
| June 24, 2022 |
DEF 14A 1 tm2219074-1def14a.htm DEF 14A TABLE OF CONTENTS SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy |
|
| June 3, 2022 |
As filed with the Securities and Exchange Commission on June 3, 2022 As filed with the Securities and Exchange Commission on June 3, 2022 Registration No. |
|
| June 3, 2022 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Accolade, Inc. (Exact name of Registrant as Specified in its Charter) Table 1 ? Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $0.0001 par value p |
|
| May 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the fiscal year ended February 28, 2022 ? OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to Commission File Number: 001-39348 ACCOLADE, INC. |
|
| May 2, 2022 |
Subsidiaries of the Registrant Exhibit 21.1 Accolade, Inc. Subsidiaries of the Registrant ? ? The following is a list of the Company?s consolidating subsidiaries as of February 28, 2022. ? ? ? Name of Subsidiary State or Jurisdiction of Incorporation Accolade Techologies s.r.o. ? Czech Republic MD Insider, Inc. ? Delaware Accolade 2ndMD LLC ? Texas 1stMD LLC ? Texas PlushCare, Inc. ? Delaware PlushCare Technologies Canada, Inc. |
|
| May 2, 2022 |
? ? ? ? ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ? ? (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: February 28, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q F |
|
| April 28, 2022 |
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2022 Exhibit 99.1 ? Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2022 ? ? Fiscal fourth quarter 2022 revenue of $93.8 million, a 58% increase compared to fiscal fourth quarter 2021 revenue of $59.2 million ? Fiscal year 2022 revenue of $310.0 million, an 82% increase compared to fiscal year 2021 revenue of $170.4 million SEATTLE, April 28, 2022 - Accolade, Inc. (NASDAQ: ACCD) toda |
|
| April 28, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2022 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) ? ? ? ? Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| March 25, 2022 |
As filed with the Securities and Exchange Commission on March 25, 2022. As filed with the Securities and Exchange Commission on March 25, 2022. Registration No. 333-254291 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ACCOLADE, INC. (Exact name of Registrant as specified in its charter) Delaware 7389 01-0969591 (State or other jurisdiction of in |
|
| February 14, 2022 |
HMIN / Homeinns Hotel Group / Andreessen Horowitz Fund IV, L.P. - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Accolade, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00437E102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ? R |
|
| February 9, 2022 |
HMIN / Homeinns Hotel Group / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Accolade Inc. Title of Class of Securities: Common Stock CUSIP Number: 00437E102 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule 13d-1(b) ??Rule 13d- |
|
| February 9, 2022 |
HMIN / Homeinns Hotel Group / ARK Investment Management LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. |
|
| January 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 10, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2022 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| January 10, 2022 |
Accolade Announces Results for Fiscal Third Quarter 2022 Exhibit 99.1 ? Accolade Announces Results for Fiscal Third Quarter 2022 ? ? Fiscal third quarter 2022 revenue of $83.5 million, a 117% increase compared to fiscal third quarter 2021 revenue of $38.4 million ? Company introduces preliminary guidance for fiscal year 2023, expecting 25% growth in revenue and a reduction in Adjusted EBITDA loss ? Initial Accolade One and Accolade Care customers launch |
|
| October 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 7, 2021 |
Accolade Announces Results for Fiscal Second Quarter 2022 Exhibit 99.1 ? Accolade Announces Results for Fiscal Second Quarter 2022 ? ? Fiscal second quarter 2022 revenue of $73.3 million, a 99% increase compared to fiscal second quarter 2021 revenue of $36.8 million ? Introduced Personalized Healthcare category, focused on human relationships and personalization using data to enable value-based care ? Launched Accolade One and Accolade Care, two new heal |
|
| October 7, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) ? ? ? ? Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| September 17, 2021 |
Filed Pursuant to Rule 424(b)(7) Registration No. 333-257803 Supplement No. 1 (To Prospectus dated July 9, 2021) 7,117,051 Shares Common Stock This prospectus supplement updates and amends certain information contained in the prospectus dated July 9, 2021 (the ?prospectus?), covering resale by selling stockholders of 7,117,051 shares of our common stock. This prospectus supplement is not complete |
|
| July 26, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| July 9, 2021 |
Form of Common Stock Warrant Agreement and Warrant Certificate Exhibit 4.9 ACCOLADE, INC. and , As Warrant Agent Form of Common Stock Warrant Agreement Dated As Of Accolade, Inc. Form of Common Stock Warrant Agreement This Common Stock Warrant Agreement (this ?Agreement?), dated as of [?], between Accolade, Inc., a Delaware corporation (the ?Company?), and [?], a [corporation] [national banking association] organized and existing under the laws of [?] and hav |
|
| July 9, 2021 |
Form of Debt Securities Warrant Agreement and Warrant Certificate Exhibit 4.11 ACCOLADE, INC. and , As Warrant Agent Form of Debt Securities Warrant Agreement Dated As Of Accolade, Inc. Form of Debt Securities Warrant Agreement This Debt Securities Warrant Agreement (this ?Agreement?), dated as of [?], between Accolade, Inc., a Delaware corporation (the ?Company?), and [?], a [corporation] [national banking association] organized and existing under the laws of [ |
|
| July 9, 2021 |
Form of Indenture, between Registrant and one or more trustees to be named Exhibit 4.7 ACCOLADE, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [?], 20 Senior Debt Securities TABLE OF CONTENTS PAGE article 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 article 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 5 Section 2.01 Designation and Terms of Securities 5 Section 2.02 Form of Securities and Trustee?s Certificate 8 Secti |
|
| July 9, 2021 |
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on July 9, 2021 Registration No. |
|
| July 9, 2021 |
Form of Preferred Stock Warrant Agreement and Warrant Certificate Exhibit 4.10 ACCOLADE, INC. and , As Warrant Agent Form of Preferred Stock Warrant Agreement Dated As Of Accolade, Inc. Form of Preferred Stock Warrant Agreement This Preferred Stock Warrant Agreement (this ?Agreement?), dated as of [?], between Accolade, Inc., a Delaware corporation (the ?Company?), and [?], a [corporation] [national banking association] organized and existing under the laws of [ |
|
| July 8, 2021 |
Accolade Announces Results for Fiscal First Quarter 2022 EX-99.1 2 accd-20210708xex99d1.htm EX-99.1 Exhibit 99.1 Accolade Announces Results for Fiscal First Quarter 2022 ● Fiscal first quarter 2022 revenue of $59.5 million, a 66% increase compared to fiscal first quarter 2021 revenue of $35.9 million ● Company raises guidance for fiscal year 2022 to $300 million - $305 million, a 78% increase at the midpoint compared to fiscal year 2021 revenue of $170. |
|
| July 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 8, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 8, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) ? ? ? ? Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission |
|
| June 25, 2021 |
proxy statement on Schedule 14A filed on June 25, 2021 TABLE OF CONTENTS SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| June 10, 2021 |
PlushCare, Inc. Stock Incentive Plan. Exhibit 99.1 PLUSHCARE, INC. STOCK INCENTIVE PLAN 1. Establishment, Purpose and Term of Plan. 1.1 Establishment. The PlushCare, Inc. Stock Incentive Plan is hereby established effective as of April 8, 2014 and amended on October 19, 2016, May 14, 2020 and August 6, 2020. 1.2 Purpose. The purpose of the Plan is to advance the interests of the Participating Company Group and its stockholders by prov |
|
| June 10, 2021 |
As filed with the Securities and Exchange Commission on June 9, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Accolade, Inc. (Exact name of registrant as specified in its charter) Delaware 01-0969591 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer I |
|
| June 10, 2021 |
Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| June 10, 2021 |
Exhibit 2.1 STRICTLY CONFIDENTIAL AMENDED EXECUTION VERSION AGREEMENT AND PLAN OF MERGER BY AND AMONG ACCOLADE, INC., PANDA MERGER SUB, INC., PLUSHCARE, INC., AND FORTIS ADVISORS LLC, AS STOCKHOLDER REPRESENTATIVE April 22, 2021 TABLE OF CONTENTS Page ARTICLE I THE MERGER 7 1.1 Merger 7 1.2 Effective Time 7 1.3 Effects of the Merger 7 1.4 Closing 7 1.5 Closing Deliverables 8 1.6 Certificate of Inc |
|
| June 10, 2021 |
Exhibit 4.1 CONFIDENTIAL EXHIBIT G REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of June 9, 2021, by and among Accolade, Inc., a Delaware corporation (the ?Company?), and the stockholders listed on the Schedule of Holders on Exhibit A hereto (individually, together with its permitted designees and assigns, the ?Holder? and collectively, the ?Holders?). Ca |
|
| June 10, 2021 |
Form of agreements used in connection with the PlushCare, Inc. Stock Incentive Plan. Exhibit 99.2 PLUSHCARE, INC. STOCK INCENTIVE PLAN RESTRICTED STOCK PURCHASE AGREEMENT This Restricted Stock Purchase Agreement (the ?Agreement?) is made and entered into as of the date specified on Carta (the ?Effective Date?) by and between PlushCare, Inc., a Delaware corporation (the ?Company?), and the purchaser indicated on Carta (?Purchaser?), by their mutual acceptance of this Agreement via |
|
| June 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| June 1, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| June 1, 2021 |
Exhibit 10.1 SIXTH AMENDMENT TO CREDIT AGREEMENT This Sixth Amendment to Credit Agreement (this ?Amendment?) is made as of May 26, 2021, by and among Accolade, Inc. (?Borrower?), MD Insider, Inc., Accolade 2ndMD LLC, 1st.MD, LLC, the financial institutions signatory hereto (the ?Lenders?) and Comerica Bank, as agent for the Lenders (in such capacity, ?Agent?). RECITALS A. Borrower, Agent and Lende |
|
| May 11, 2021 |
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on May 10, 2021. |
|
| May 7, 2021 |
? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the fiscal year ended February 28, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to Commission File Number: 001-39348 ACCOLADE, INC. (E |
|
| May 7, 2021 |
Subsidiaries of the Registrant Exhibit 21.1 Accolade, Inc. Subsidiaries of the Registrant ? ? The following is a list of the Company?s consolidating subsidiaries as of February 28, 2021. Name of Subsidiary State or Jurisdiction of Incorporation Accolade Techologies sro ? Czech Republic MD Insider, Inc. ? Delaware ? |
|
| May 7, 2021 |
Description of the Registrant’s Securities Exhibit 4.6 ? DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a description of the common stock, $0.0001 par value per share (?Common Stock?) of Accolade, Inc. (the ?Company,? ?we,? ?our,? or ?us?), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, |
|
| May 7, 2021 |
? Exhibit 10.13 ? FIFTH AMENDMENT TO CREDIT AGREEMENT This Fifth Amendment to Credit Agreement (this ?Amendment?) is made as of March 23, 2021, by and among Accolade, Inc. (?Borrower?), MD Insider, Inc., the financial institutions signatory hereto (the ?Lenders?) and Comerica Bank, as agent for the Lenders (in such capacity, ?Agent?). RECITALS A.Borrower, Agent and Lenders entered into that certai |
|
| May 6, 2021 |
CORRECTION -- Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2021 Exhibit 99.1 ? CORRECTION - Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2021 ? ? Fiscal fourth quarter 2021 revenue of $59.2 million, a 33% increase compared to fiscal fourth quarter 2020 revenue of $44.4 million ? Fiscal year 2021 revenue of $170.4 million, a 29% increase compared to fiscal year 2020 revenue of $132.5 million ? Initiates guidance for fiscal year 2022 revenu |
|
| May 6, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) ? ? ? ? Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 5, 2021 |
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2021 Exhibit 99.1 ? Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2021 ? ? Fiscal fourth quarter 2021 revenue of $59.2 million, a 33% increase compared to fiscal fourth quarter 2020 revenue of $44.4 million ? Fiscal year 2021 revenue of $170.4 million, a 29% increase compared to fiscal year 2020 revenue of $132.5 million ? Initiates guidance for fiscal year 2022 revenue in the rang |
|
| May 5, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) ? ? ? ? Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission |
|
| April 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| April 23, 2021 |
Exhibit 99.1 Accolade to Acquire PlushCare ? Accolade to begin offering virtual primary care and mental health consultations directly to members as a result of the acquisition. ? $200bn+ combined target addressable market materially expands opportunity to reinvent healthcare with a focus on improving health outcomes and managing rising costs. ? Combined with Accolade?s proven ability to deliver co |
|
| April 23, 2021 |
Investor Presentation issued by Accolade,Inc., dated April 23, 2021 Exhibit 99.2 1 Accolade Announces Acquisition of PlushCare 2 This presentation contains ?forward-looking statements? ?that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such ??anticipate,?? ??believe,?? ??contemplate,?? ??continue,? |
|
| April 6, 2021 |
TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(3)? ?Registration No. 333-254291? PROSPECTUS 2,495,441 Shares COMMON STOCK ? This prospectus relates to the sale or other disposition from time to time of up to 2,495,441 shares of our common stock, which are held by the selling stockholders named in this prospectus. The shares of common stock covered by this prospectus were previously issued by us |
|
| April 1, 2021 |
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on April 1, 2021. |
|
| April 1, 2021 |
EX-10.33 3 tm218310d8ex10-33.htm EXHIBIT 10.33 Exhibit 10.33 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE ACCOLADE, INC. HAS DETERMINED THE INFORMATION IS NOT MATERIAL. STATEMENT OF WORK NO. 3 This is Statement of Work (“SOW”) No. 03 to the MASTER SERVICES AGREEMENT dated December 19, 2016 (the “Agreement”), between United HealthCare Servi |
|
| April 1, 2021 |
Exhibit 10.32 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE ACCOLADE, INC. HAS DETERMINED THE INFORMATION IS NOT MATERIAL. MASTER SERVICES AGREEMENT This Master Services Agreement (?Agreement?) is made as of December 19, 2016 (the ?Effective Date?), between: United HealthCare Services, Inc., a Minnesota corporation with offices at 9900 Bren |
|
| April 1, 2021 |
Accolade, Inc. 1201 Third Avenue, Suite 1700 Seattle, WA 98101 April 1, 2021 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Scott Anderegg RE: Accolade, Inc. Registration Statement on Form S-1 File No. 333-254291 Ladies and Gentlemen: Accolade, Inc. (the ?Registrant?) hereby requests that the |
|
| March 29, 2021 |
Accolade Announces Private Offering of $250 Million Convertible Notes EX-99.1 4 tm2111178d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Accolade Announces Private Offering of $250 Million Convertible Notes SEATTLE – March 23, 2021 - Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced today that it intends to offer, subject to market and other conditions, $250 million aggregate principal amount of convertible senior notes due 2026 (the “Notes”) in a private placement (the “ |
|
| March 29, 2021 |
Form of Confirmation for Capped Call Transactions. EX-10.1 3 tm2111178d1ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Bidding Form 3/23/21 [] [Dealer name and address] To: Accolade, Inc. [ ] From: [Dealer] Re: [Base]1 [Additional]2 Capped Call Transaction Ref. No: []3 Date: March [ ], 2021 Dear Ladies and Gentlemen: The purpose of this communication (this “Confirmation”) is to set forth the terms and conditions of the above-referenced transaction entered i |
|
| March 29, 2021 |
EX-4.1 2 tm2111178d1ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 Execution Version ACCOLADE, Inc. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of March 29, 2021 0.50% Convertible Senior Notes due 2026 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions 1 Section 1.02 References to Interest 14 ARTICLE 2 ISSUE, DESCRIPTION, EXECUTION, REGISTRATION AND EXCHANGE OF NOTES |
|
| March 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| March 29, 2021 |
Accolade Announces Pricing of $250 Million Convertible Senior Notes Offering EX-99.2 5 tm2111178d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Accolade Announces Pricing of $250 Million Convertible Senior Notes Offering SEATTLE – March 24, 2021 - Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced the pricing of $250 million aggregate principal amount of 0.50% convertible senior notes due 2026 (the “Notes”) in a private placement (the “offering”) to qualified institutional buyers |
|
| March 23, 2021 |
Accolade Announces Preliminary Results for Fourth Quarter and Full Year of Fiscal Year 2021 Exhibit 99.2 Accolade Announces Preliminary Results for Fourth Quarter and Full Year of Fiscal Year 2021 Seattle, WA, March 23, 2021 ? Accolade, Inc. (Nasdaq: ACCD) today provided preliminary unaudited financial results for the fiscal fourth quarter and year ended February 28, 2021 (fiscal year 2021). Based on current information, the company expects to report revenue for the fiscal 2021 fourth qu |
|
| March 23, 2021 |
Accolade Announces Private Offering of $250 Million Convertible Notes Exhibit 99.1 Accolade Announces Private Offering of $250 Million Convertible Notes SEATTLE – March 23, 2021 - Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced today that it intends to offer, subject to market and other conditions, $250 million aggregate principal amount of convertible senior notes due 2026 (the “Notes”) in a private placement (the “offering”) to qualified institutional buyers |
|
| March 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| March 15, 2021 |
Amended and Restated Non-Employee Director Compensation Policy. EX-10.31 4 tm218310d5ex10-31.htm EXHIBIT 10.31 Exhibits 10.31 Accolade, Inc. Amended and Restated Non-Employee Director Compensation Policy Effective Date: February 15, 2021 Each member of the Board of Directors (the “Board”) who is not also serving as an employee of or consultant to Accolade, Inc. (the “Company”) or any of its subsidiaries (each such member, an “Eligible Director”) will receive t |
|
| March 15, 2021 |
Offer Letter by and between the Registrant and Stephen Barnes dated December 1, 2014 EX-10.6 3 tm218310d5ex10-6.htm EXHIBIT 10.6 Exhibit 10.6 December 1, 2014 Personal and Confidential Steve Barnes 967 Ethan Allen Road Berwyn, PA 19312 Dear Steve: On behalf of the team at Accolade, Inc., I am delighted to offer you employment with Accolade, Inc. (the "Company"), commencing on or before February 1, 2015 (the "Commencement Date"). The following are some of the more significant benef |
|
| March 15, 2021 |
As filed with the Securities and Exchange Commission on March 15, 2021. TABLE OF CONTENTS As filed with the Securities and Exchange Commission on March 15, 2021. |
|
| March 4, 2021 |
Exhibit 2.1 STRICTLY CONFIDENTIAL EXECUTION VERSION AGREEMENT AND PLAN OF MERGER BY AND AMONG Accolade, inc., MAESTRO MERGER SUB, LLC, Innovation specialists llc d/b/a 2nd.md, AND shareholder representative services llc, AS MEMBER Representative January 14, 2021 TABLE OF CONTENTS Article I THE MERGER 2 1.1 Merger 2 1.2 Effective Time 2 1.3 Effects of the Merger 2 1.4 Closing; Closing Deliverables |
|
| March 4, 2021 |
Exhibit 4.1 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of March 3, 2021, by and among Accolade, Inc., a Delaware corporation (the ?Company?), and the stockholders listed on the Schedule of Holders on Exhibit A hereto (individually, together with its permitted designees and assigns, the ?Holder? and collectively, the ?Holders?). Capitalized terms used h |
|
| March 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 4, 2021 |
EX-10.1 4 tm218687d1ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 FOURTH AMENDMENT TO CREDIT AGREEMENT This Fourth Amendment to Credit Agreement (this “Amendment”) is made as of March 2, 2021, by and among Accolade, Inc. (“Borrower”), MD Insider, Inc., the financial institutions signatory hereto (the “Lenders”) and Comerica Bank, as agent for the Lenders (in such capacity, “Agent”). RECITALS A. Borrower, A |
|
| February 16, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Accolade, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00437E102 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨ Ru |
|
| February 2, 2021 |
SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Accolade, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 00437E 102 (CUSIP Number) Anne-Marie F. Shelley, Esq. General Counsel and Chief Compliance Officer Accretive, LLC 660 Madison Avenue 12th Floor, Suite |
|
| January 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 24, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| January 27, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* ACCOLADE, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 00437E102 (CUSIP Number) James C. Madden, V. Marc F. McMorris Managing Members Carrick Management Partners, LLC Carrick Management Partners II, LLC 610 Newport Cen |
|
| January 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 14, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| January 14, 2021 |
1 1 AccoladeAnnounces Acquisitionof2nd.MD Exhibit 99.2 1 1 AccoladeAnnounces Acquisitionof2nd.MD 2 2 2 2 This presentation contains “forward-looking statements” –that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such ‘‘anticipate,’’ ‘‘believe,’’ ‘‘contemplate,’’ ‘‘continue |
|
| January 14, 2021 |
EX-99.1 2 tm213147d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Accolade to Acquire 2nd.md The addition of 2nd.MD’s Expert Medical Opinion services to Accolade’s portfolio of high-touch, technology-enabled health and benefits solutions expands Accolade’s clinical capabilities and creates the market’s most comprehensive, integrated healthcare navigation experience. Seattle, WA, January 14, 2021 – Accolade |
|
| January 7, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2021 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| January 7, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 |
|
| January 7, 2021 |
Accolade Announces Results for Fiscal Third Quarter 2021 EX-99.1 2 tmb-20210107xex99d1.htm EX-99.1 Exhibit 99.1 Accolade Announces Results for Fiscal Third Quarter 2021 ●Fiscal third quarter 2021 revenue of $38.4 million, a 30% increase compared to fiscal third quarter 2020 revenue of $29.7 million, driven primarily by strength in new customer additions across market segments and offerings ●Company raises revenue outlook for fiscal year 2021 to a range |
|
| November 9, 2020 |
Exhibit 10.1 THIRD AMENDMENT TO CREDIT AGREEMENT This Third Amendment to Credit Agreement (this “Amendment”) is made as of November 6, 2020 by and among Accolade, Inc. (“Borrower”), MD Insider, Inc., the financial institutions signatory hereto (the “Lenders”) and Comerica Bank, as agent for the Lenders (in such capacity, “Agent”). RECITALS A. Borrower, Agent and Lenders entered into that certain C |
|
| November 9, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2020 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| October 22, 2020 |
Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS 2 Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. |
|
| October 22, 2020 |
As filed with the Securities and Exchange Commission on October 21, 2020. Registration No. 333-249540 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ACCOLADE, INC. (Exact name of Registrant as specified in its charter) Delaware 7389 01-0969591 (State or other jurisdiction of |
|
| October 21, 2020 |
As filed with the Securities and Exchange Commission on October 21, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ACCOLADE, INC. (Exact name of Registrant as specified in its charter) Delaware 7389 01-0969591 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Emp |
|
| October 19, 2020 |
Accolade, Inc. 1201 Third Avenue, Suite 1700 Seattle, WA 98101 Accolade, Inc. 1201 Third Avenue, Suite 1700 Seattle, WA 98101 October 19, 2020 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Information Technologies and Services 100 F Street, N.E. Washington, D.C. 20549 RE: Accolade, Inc. Registration Statement on Form S-1 File No. 333-249540 Ladies and Gentlemen: Accolade, Inc. (the ?Registrant?) hereby requests that the Sec |
|
| October 19, 2020 |
[Remainder of page intentionally left blank] October 19, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549 Re: Accolade, Inc. Registration Statement on Form S-1 (File No. 333-249540) Ladies and Gentleman: In connection with the above-referenced Registration Statement and pursuant to Rule 461 under the Securities Act of 1933, as amended (the ?Act?), we, as representat |
|
| October 19, 2020 |
Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS 2 Table of Contents As filed with the Securities and Exchange Commission on October 19, 2020. |
|
| October 19, 2020 |
Form of Underwriting Agreement. Exhibit 1.1 Accolade, Inc. Common Stock Underwriting Agreement [·], 2020 Goldman Sachs & Co. LLC Morgan Stanley & Co. LLC BofA Securities, Inc. As representatives of the several Underwriters named in Schedule I hereto, c/o Goldman Sachs & Co. LLC 200 West Street New York, New York 10282-2198 c/o Morgan Stanley & Co. LLC 1585 Broadway New York, NY 10036 c/o BofA Securities, Inc. One Bryant Park New |
|
| October 14, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 14, 2020 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| October 14, 2020 |
SECOND AMENDMENT TO CREDIT AGREEMENT This Second Amendment to Credit Agreement (this “Amendment”) is made as of September 11, 2020 by and among Accolade, Inc. |
|
| October 14, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 A |
|
| October 14, 2020 |
Accolade Announces Results for Fiscal Second Quarter 2021 Exhibit 99.1 Accolade Announces Results for Fiscal Second Quarter 2021 ● Fiscal second quarter 2021 revenue of $36.8 million, a 24% increase compared to fiscal second quarter 2020 revenue of $29.7 million, driven primarily by strength in new customer adds across segments and offerings ● Continued bookings momentum driving strength in new customer adds across segments and offerings SEATTLE, October |
|
| October 9, 2020 |
Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS 2 Table of Contents As confidentially submitted to the Securities and Exchange Commission on October 9, 2020. |
|
| August 25, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2020 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| August 25, 2020 |
Exhibit 10.1 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE ACCOLADE, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO ACCOLADE, INC. IF PUBLICLY DISCLOSED. FIRST AMENDMENT TO CREDIT AGREEMENT This First Amendment to Credit Agreement (this “Amendment”) is made as of August 21, 2020 by an |
|
| August 13, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 ACCO |
|
| August 13, 2020 |
Accolade Announces Results for Fiscal First Quarter 2021 Exhibit 99.1 Accolade Announces Results for Fiscal First Quarter 2021 ● Fiscal first quarter 2021 revenue of $35.9 million, a 25% increase compared to fiscal first quarter 2020 revenue of $28.8 million, driven primarily by strength in new customer adds across segments and offerings ● Launched pilot with Defense Health Agency, our first customer in the federal government sector ● Provides fiscal se |
|
| August 13, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2020 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| July 27, 2020 |
Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2020 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| July 16, 2020 |
Exhibit 1 CUSIP No. 000437E 102 SCHEDULE 13D Page 21 of 22 Pages EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13D with respect to the shares of the common stock of Accolade, Inc. is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rul |
|
| July 16, 2020 |
ACCD / Accolade, Inc. / CLINE J MICHAEL - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* Accolade, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 00437E 102 (CUSIP Number) Anne-Marie F. Shelley, Esq. General Counsel and Chief Compliance Officer Accretive, LLC 660 Madison Avenue 12th Floor, Suite 121 |
|
| July 13, 2020 |
ACCD / Accolade, Inc. / Carrick Management Partners II, LLC Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 ACCOLADE, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 00437E102 (CUSIP Number) James C. Madden, V. Marc F. McMorris Managing Members Carrick Management Partners, LLC Carrick Management Partners II, LLC 610 Newport Center Drive, Suite 12 |
|
| July 13, 2020 |
Joint Filing Agreement, dated July 7, 2020, by and among the Reporting Persons (filed herewith). Exhibit 1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. |
|
| July 10, 2020 |
Amended and Restated Certificate of Incorporation of Accolade, Inc. Exhibit 3.1 eighth Amended and Restated CERTIFICATE OF INCORPORATION OF ACCOLADE, INC. (Pursuant to Sections 228, 242 and 245 of the General Corporation Law of the State of Delaware) Rajeev Singh hereby certifies that: ONE: The date of filing the original Certificate of Incorporation of this corporation with the Secretary of State of the State of Delaware was June 14, 2010. TWO: He is the duly ele |
|
| July 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2020 Accolade, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39348 01-0969591 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| July 6, 2020 |
As filed with the Securities and Exchange Commission on July 6, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Accolade, Inc. (Exact name of registrant as specified in its charter) Delaware 01-0969591 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer I |
|
| July 2, 2020 |
10,022,726 Shares Common Stock Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS 2 Filed Pursuant to Rule 424(b)(4) Registration No. |
|
| July 1, 2020 |
As filed with the Securities and Exchange Commission on July 1, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ACCOLADE, INC. (Exact name of Registrant as specified in its charter) Delaware 7389 01-0969591 (State or other jurisdiction of incorporation or organization) (Primary Sta |
|
| July 1, 2020 |
QuickLinks - Click here to rapidly navigate through this document As filed with the Securities and Exchange Commission on June 30, 2020. |
|
| June 30, 2020 |
Table of Contents As filed with the Securities and Exchange Commission on June 29, 2020. |
|
| June 29, 2020 |
June 29, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549 Attn: Dieterich King Eric Envall Doug Jones Keira Nakada Re: Accolade, Inc. Registration Statement on Form S-1 (File No. 333-236786) Ladies and Gentleman: In connection with the above-referenced Registration Statement and pursuant to Rule 461 under the Securities A |
|
| June 29, 2020 |
Accolade, INC. 1201 Third Avenue, Suite 1700 Seattle, WA 98101 June 29, 2020 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Information Technologies and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Dieterich King Eric Envall Doug Jones Keira Nakada RE: Accolade, Inc. Registration Statement on Form S-1 File No. 333-236786 Ladies and Gentlemen: Acc |
|
| June 29, 2020 |
June 29, 2020 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Keira Nakada Doug Jones Eric Envall Dietrich King Re: Accolade, Inc. Amendment No. 3 to Registration Statement on Form S-1 Submitted February 28, 2020 File No. 333-236786 Dear Ms. Nakada and Messrs. Jones, Envall and King: On behalf of Accolade, Inc. (“Accolade” or |
|
| June 26, 2020 |
June 26, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549 Attn: Dieterich King Eric Envall Doug Jones Keira Nakada Re: Accolade, Inc. Registration Statement on Form S-1 (File No. 333-236786) Ladies and Gentleman: In connection with the above-referenced Registration Statement and pursuant to Rule 461 under the Securities A |
|
| June 26, 2020 |
June 26, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549 Attn: Dieterich King Eric Envall Doug Jones Keira Nakada Re: Accolade, Inc. Registration Statement on Form S-1 (File No. 333-236786) Ladies and Gentleman: In connection with the above-referenced Registration Statement and pursuant to Rule 461 under the Securities A |
|
| June 25, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Accolade, Inc. |
|
| June 24, 2020 |
Table of Contents As filed with the Securities and Exchange Commission on June 24, 2020. |
|
| June 24, 2020 |
June 24, 2020 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Keira Nakada Doug Jones Eric Envall Dietrich King Re: Accolade, Inc. Amendment No. 2 to Registration Statement on Form S-1 Submitted February 28, 2020 File No. 333-236786 Dear Ms. Nakada and Messrs. Jones, Envall and King: On behalf of Accolade, Inc. (“Accolade” or |
|
| June 24, 2020 |
Exhibit 10.32 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE ACCOLADE, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO ACCOLADE, INC. IF PUBLICLY DISCLOSED. SECOND RENEWAL AND AMENDMENT OF THE AMENDED AND RESTATED SERVICES AGREEMENT This “Second Renewal and Amendment” is to the AMENDED |
|
| June 24, 2020 |
Form of Underwriting Agreement. Exhibit 1.1 Accolade, Inc. Common Stock Underwriting Agreement , 2020 Goldman Sachs & Co. LLC Morgan Stanley & Co. LLC BofA Securities, Inc. As representatives of the several Underwriters named in Schedule I hereto, c/o Goldman Sachs & Co. LLC 200 West Street New York, New York 10282-2198 c/o Morgan Stanley & Co. LLC 1585 Broadway New York, NY 10036 c/o BofA Securities, Inc. One Bryant Park New Yo |
|
| June 16, 2020 |
EX-3.3 3 a2240867zex-33.htm EX-3.3 Exhibit 3.3 EIGHTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ACCOLADE, INC. RAJEEV SINGH hereby certifies that: ONE: The date of filing the original Certificate of Incorporation of this corporation with the Secretary of State of the State of Delaware was June 14, 2010. TWO: He is the duly elected and acting Chief Executive Officer of Accolade, Inc., a |
|
| June 16, 2020 |
Offer Letter by and between the Registrant and Michael Hilton dated October 19, 2015. Exhibit 10.6 October 19, 2015 Personal and Confidential Michael Hilton Address to be provided Dear Michael: On behalf of the team at Accolade, I am delighted to offer you employment as Chief Product Officer commencing on or before November 2, 2015 reporting to Rajeev Singh, Chief Executive Officer. This letter sets out some of the more significant terms and conditions of your employment. Your base |
|
| June 16, 2020 |
Non-Employee Director Compensation Policy. Exhibit 10.33 ACCOLADE, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY EFFECTIVE DATE: MARCH 26, 2020 Each member of the Board of Directors (the “Board”) who is not also serving as an employee of or consultant to Accolade, Inc. (the “Company”) or any of its subsidiaries (each such member, an “Eligible Director”) will receive the compensation described in this Non-Employee Director Compensation Pol |
|
| June 16, 2020 |
Exhibit 10.11 Execution Copy THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT This THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT, dated as of May 7, 2020 (this “Amendment”), is entered into by and among ACCOLADE, INC., a Delaware corporation (“Accolade”), MD INSIDER, INC., a Delaware corporation (together with Accolade, collectively, “Borrower”), and ESCALATE CAPITAL PARTNERS SBIC III, LP, a Delawa |
|
| June 16, 2020 |
Accolade, Inc. 2020 Equity Incentive Plan and forms of agreements thereunder. Exhibit 10.2 ACCOLADE, INC. 2020 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 28, 2020 APPROVED BY THE STOCKHOLDERS: MARCH 10, 2020 TABLE OF CONTENTS Page 1. GENERAL 1 2. SHARES SUBJECT TO THE PLAN 1 3. ELIGIBILITY AND LIMITATIONS 2 4. OPTIONS AND STOCK APPRECIATION RIGHTS 3 5. AWARDS OTHER THAN OPTIONS AND STOCK APPRECIATION RIGHTS 6 6. ADJUSTMENTS UPON CHANGES IN COMMON STOC |
|
| June 16, 2020 |
Accolade, Inc. 2020 Employee Stock Purchase Plan. Exhibit 10.3 ACCOLADE, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 28, 2020 APPROVED BY THE STOCKHOLDERS: MARCH 10, 2020 1. GENERAL; PURPOSE. (a) The Plan provides a means by which Eligible Employees of the Company and certain designated Related Corporations may be given an opportunity to purchase shares of Common Stock. The Plan permits the Company to grant |
|
| June 16, 2020 |
June 16, 2020 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Keira Nakada Doug Jones Eric Envall Dietrich King Re: Accolade, Inc. Amendment No. 1 to Registration Statement on Form S-1 Submitted February 28, 2020 File No. 333-236786 Dear Ms. Nakada and Messrs. Jones, Envall and King: On behalf of Accolade, Inc. (“Accolade” or |
|
| June 16, 2020 |
Exhibit 3.1 SEVENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ACCOLADE, INC. a Delaware Corporation (Pursuant to Sections 228, 242 and 245 of the General Corporation Law of the State of Delaware) ACCOLADE, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware, DOES HEREBY CERTIFY: FIRST: The original Certificate of Incorporation of Accolad |
|
| June 16, 2020 |
Table of Contents As filed with the Securities and Exchange Commission on June 16, 2020. |
|
| June 16, 2020 |
Accolade, Inc. Amended and Restated 2007 Stock Option Plan, and forms of agreements thereunder. Exhibit 10.1 ACCOLADE, INC. AMENDED AND RESTATED 2007 STOCK OPTION PLAN AS AMENDED AND RESTATED EFFECTIVE APRIL 25, 2014 ARTICLE ONE GENERAL PROVISIONS I. PURPOSE OF THE PLAN This Amended and Restated 2007 Stock Option Plan is intended to promote the interests of Accolade, Inc., successor-in-interest to Accolade LLC (the “Company”), by providing eligible persons with the opportunity to acquire a p |
|
| February 28, 2020 |
Offer Letter by and between the Registrant and Robert Cavanaugh dated October 26, 2015. Exhibit 10.7 ACCOLADE. October 26, 2015 Personal and Confidential Robert Cavanaugh 1030 Riverhaven Drive Suwanee, GA 30024 Dear Rob: On behalf of the team at Accolade, I am delighted to offer you employment as President, Field Operations commencing on or before October 30, 2015 reporting to Raj Singh, CEO. This letter sets out some of the more significant terms and conditions of your employment. Y |
|
| February 28, 2020 |
Exhibit 4.2 ACCOLADE, INC. FIFTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT DATED AS OF OCTOBER 2, 2019 FIFTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS FIFTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of October 2, 2019 is made by and among ACCOLADE, INC., a Delaware corporation (the ?Company?), and the Persons (as defined below) set forth |
|
| February 28, 2020 |
Exhibit 10.26 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE ACCOLADE, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO ACCOLADE, INC. IF PUBLICLY DISCLOSED. AMENDMENT AND RESTATEMENT OF EXHIBITS F AND G TO THE AMENDED AND RESTATED SERVICES AGREEMENT ?EXHIBIT F? and ?EXHIBIT G? to the AM |
|
| February 28, 2020 |
EX-10.24 31 a2240822zex-1024.htm EX-10.24 Exhibit 10.24 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE ACCOLADE, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO ACCOLADE, INC. IF PUBLICLY DISCLOSED. AMENDMENT TO EXHIBITS F AND G TO THE AMENDED AND RESTATED SERVICES AGREEMENT This “Amend |
|
| February 28, 2020 |
Exhibit 10.20 ORIGINAL SIXTH AMENDMENT TO LEASE This Sixth Amendment to Lease (?Amendment?) made and entered into this 7th day of March, 2012, between and among BRANDYWINE OPERATING PARTNERSHIP, L.P. (?Landlord?) and ACCOLADE, INC. (?Tenant?). WHEREAS, Landlord leases certain premises consisting of 30,617 rentable square feet (?RSF?) of space commonly referred to as Suites 300 and 450 (collectivel |
|
| February 28, 2020 |
Accolade, Inc. 2020 Equity Incentive Plan and forms of agreements thereunder. Exhibit 10.2 ACCOLADE, INC. 2020 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 28, 2020 APPROVED BY THE STOCKHOLDERS: , 2020 TABLE OF CONTENTS Page 1. GENERAL 1 2. SHARES SUBJECT TO THE PLAN 1 3. ELIGIBILITY AND LIMITATIONS 2 4. OPTIONS AND STOCK APPRECIATION RIGHTS 3 5. AWARDS OTHER THAN OPTIONS AND STOCK APPRECIATION RIGHTS 6 6. ADJUSTMENTS UPON CHANGES IN COMMON STOCK; OTHER |
|
| February 28, 2020 |
Exhibit 10.17 ORIGINAL THIRD AMENDMENT TO LEASE This ?Third Amendment to Lease? made and entered into this 5th day of August, 2010, by and between BRANDYWINE OPERATING PARTNERSHIP, L.P., hereinafter referred to as (?Landlord?) and ACCOLADE, INC., a Delaware corporation and successor to Accolade LLC, hereinafter referred to as (?Tenant?). WHEREAS, Landlord leased certain premises consisting of 8,69 |
|
| February 28, 2020 |
Accolade, Inc. Amended and Restated 2007 Stock Option Plan, and forms of agreements thereunder. Exhibit 10.1 ACCOLADE, INC. AMENDED AND RESTATED 2007 STOCK OPTION PLAN AS AMENDED AND RESTATED EFFECTIVE APRIL 25, 2014 ARTICLE ONE GENERAL PROVISIONS I. PURPOSE OF THE PLAN This Amended and Restated 2007 Stock Option Plan is intended to promote the interests of Accolade, Inc., successor-in-interest to Accolade LLC (the ?Company?), by providing eligible persons with the opportunity to acquire a p |
|
| February 28, 2020 |
Form of common stock certificate of the Registrant Exhibit 4.1 AC CUSIP 67054G 10 SEE REVERSE FOR CERTAIN DEFINITIONS AND LEGENDS 8 INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE This certifies that is the record holder of FULLY PAID AND NONASSESSABLE SHARES OF COMMON STOCK, $0.0001 PAR VALUE PER SHARE, OF Accolade, Inc. transferable on the books of the Corporation in person or by duly authorized attorney upon surrender of this Certificate p |
|
| February 28, 2020 |
Office Lease by and between the Registrant and 1201 Tab Owner, LLC dated May 28, 2019. Exhibit 10.31 OFFICE LEASE BETWEEN 1201 TAB OWNER, LLC (?LANDLORD?) AND ACCOLADE, INC. (?TENANT?) 1201 Third Avenue Seattle, Washington TABLE OF CONTENTS Page ARTICLE ONE BASIC LEASE PROVISIONS 1 1.01 BASIC LEASE PROVISIONS 1 1.02 ENUMERATION OF EXHIBITS 3 1.03 DEFINITIONS 3 ARTICLE TWO PREMISES, TERM, FAILURE TO GIVE POSSESSION, EARLY ACCESS AND CONDITION OF THE PREMISES 7 2.01 LEASE OF PREMISES |
|
| February 28, 2020 |
Exhibit 10.12 THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 6 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, IN THE OPINION |
|
| February 28, 2020 |
Employment Agreement by and between the Registrant and Rajeev Singh dated October 2015. EX-10.5 12 a2240822zex-105.htm EX-10.5 Exhibit 10.5 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the "Emplovment Agreement") is dated October [ ], 2015 and will be effective as of the Commencement Date (defined below), by and between Accolade, Inc. (the "Company"), and Rajeev Singh (the "Executive"). W I TN E S S E T H: WHEREAS, the Company desires to employ the Executive and the Executive desi |
|
| February 28, 2020 |
Exhibit 10.13 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [*******], HAS BEEN OMITTED BECAUSE ACCOLADE, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO ACCOLADE, INC. IF PUBLICLY DISCLOSED. AMENDMENT NO. 1 TO WARRANT TO PURCHASE COMMON STOCK OF ACCOLADE, INC. This AMENDMENT NO. l (this ?Amendment?) dated as of [ ], |
|
| February 28, 2020 |
Exhibit 10.21 SEVENTH AMENDMENT TO LEASE This Seventh Amendment to Lease (?Amendment?) made and entered into this 23rd day of October, 2012, between and among BRANDYWINE OPERATING PARTNERSHIP, L.P. (?Landlord?) and ACCOLADE, INC. (?Tenant?). WHEREAS, Landlord leases certain premises consisting of 30,617 rentable square feet (?RSF?) of space commonly referred to as Suites 300 and 450 (collectively, |
|
| February 28, 2020 |
Offer Letter by and between the Registrant and Stephen Barnes dated December 1, 2014. Exhibit 10.6 ., ACCOLADE? December 1, 2014 Personal and Confidential Steve Barnes 967 Ethan Allen Road Berwyn, PA 19312 Dear Steve: On behalf of the team at Accolade, Inc., Iam delighted to offer you employment with Accolade, Inc. (the "Company"), commencing on or before February 1, 2015 (the "Commencement Date"). The following are some of the more significant benefits and terms and conditions of |
|
| February 28, 2020 |
Amended and Restated Bylaws of the Registrant, as amended July 2016, as currently in effect. Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ACCOLADE, INC. a Delaware corporation Adopted July [?], 2016 These Amended and Restated Bylaws (?Bylaws?) amend, restate and replace the Bylaws of the corporation previously adopted on June 14, 2010. ARTICLE I OFFICES Section 1.Registered Office. The address of the initial registered office of the Corporation in the State of Delaware is State of Delaware |
|
| February 28, 2020 |
Exhibit 10.23 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE ACCOLADE, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO ACCOLADE, INC. IF PUBLICLY DISCLOSED. AMENDED AND RESTATED SERVICES AGREEMENT THIS AMENDED AND RESTATED SERVICES AGREEMENT (this ?Agreement?) is entered into this 29th |
|
| February 28, 2020 |
Table of Contents As filed with the Securities and Exchange Commission on February 28, 2020. |
|
| February 28, 2020 |
Exhibit 10.4 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the ?Agreement?) is made and entered into as of [ ], between Accolade, Inc., a Delaware corporation (the ?Company?), and [ ] (?Indemnitee?). WITNESSETH THAT: WHEREAS, highly competent persons have become more reluctant to serve corporations as directors, officers or in other capacities unless they are provided with adequate pro |
|
| February 28, 2020 |
Accolade, Inc. 2020 Employee Stock Purchase Plan. Exhibit 10.3 ACCOLADE, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 28, 2020 APPROVED BY THE STOCKHOLDERS: , 2020 1. GENERAL; PURPOSE. (a) The Plan provides a means by which Eligible Employees of the Company and certain designated Related Corporations may be given an opportunity to purchase shares of Common Stock. The Plan permits the Company to grant a series |
|
| February 28, 2020 |
Exhibit 10.29 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE ACCOLADE, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO ACCOLADE, INC. IF PUBLICLY DISCLOSED. AMENDMENT 2 TO THE AMENDED AND RESTATED SERVICES AGREEMENT (THE “AMENDMENT”) This “Amendment 2” is to the AMENDED AND RESTATED SER |
